Effects of dance on gait and dual-task gait in Parkinson's disease.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
03
03
2022
accepted:
09
11
2022
entrez:
24
1
2023
pubmed:
25
1
2023
medline:
27
1
2023
Statut:
epublish
Résumé
Gait impairments in Parkinson's disease (PD) limit independence and quality of life. While dance-based interventions could improve gait, further studies are needed to determine if the benefits generalise to different terrains and when dual-tasking. The aim was to assess the effects of a dance intervention, based on the Dance for PD® (DfPD®) program, on gait under different dual-tasks (verbal fluency, serial subtraction) and surfaces (even, uneven), and to determine if a larger scale follow-up RCT is warranted. A dance group (DG; n = 17; age = 65.8 ± 11.7 years) and a control group (CG: n = 16; age = 67.0 ± 7.7 years) comprised of non-cognitively impaired (Addenbrooke's score: DG = 93.2 ± 3.6, CG = 92.6 ± 4.3) independently locomoting people with PD (Hoehn & Yahr I-III). The DG undertook a one-hour DfPD®-based class, twice weekly for 12 weeks. The CG had treatment as usual. The spatiotemporal variables of gait were assessed at baseline and post-intervention while walking on two surfaces (even, uneven) under three conditions: regular walking; dual-task: verbal-fluency (DTVERB), and serial-subtraction (DTSUBT). The data were analysed by means of a linear mixed model. At baseline, there was no significant group difference for any spatiotemporal gait variable. The DG improved significantly compared to the CG with and without a dual task when walking on even surface. During regular walking, DG improved in gait velocity (p = 0.017), cadence (p = 0.039), step length (p = 0.040) and stride length (p = 0.041). During DTVERB significant improvements were noted in gait velocity (p = 0.035), cadence (p = 0.034) and step length (p = 0.039). The DG also exhibited significant improvement compared to the CG during DTSUBT in the measures of gait velocity (p = 0.012), cadence (p = 0.021), step length (p = 0.018), and stride length (p = 0.151). On the uneven surface, improvements were noted when walking while performing serial subtractions only. During regular walking, improvements were noted for the CG but not for the DG. CG has spent less time in double support following the intervention than DG. While DTVERB condition had no significant group differences for any gait parameter (p's >0.05), in the DTSUBT condition, the DG improved significantly compared to the controls on gait velocity (p = 0.048), cadence (p = 0.026), and step length (p = 0.051). DfPD®-based classes produced clinically significant improvement in spatiotemporal gait parameters under dual-task conditions and on uneven surfaces. This could arise from improved movement confidence and coordination; emotional expression; cognitive skills (planning, multitasking), and; utilisation of external movement cues. A large-scale RCT of this program is warranted. A protocol for this study has been registered retrospectively at the Australian New Zealand Clinical Trials Registry. Identifier: ACTRN12618001834246.
Sections du résumé
BACKGROUND
Gait impairments in Parkinson's disease (PD) limit independence and quality of life. While dance-based interventions could improve gait, further studies are needed to determine if the benefits generalise to different terrains and when dual-tasking. The aim was to assess the effects of a dance intervention, based on the Dance for PD® (DfPD®) program, on gait under different dual-tasks (verbal fluency, serial subtraction) and surfaces (even, uneven), and to determine if a larger scale follow-up RCT is warranted.
METHODS
A dance group (DG; n = 17; age = 65.8 ± 11.7 years) and a control group (CG: n = 16; age = 67.0 ± 7.7 years) comprised of non-cognitively impaired (Addenbrooke's score: DG = 93.2 ± 3.6, CG = 92.6 ± 4.3) independently locomoting people with PD (Hoehn & Yahr I-III). The DG undertook a one-hour DfPD®-based class, twice weekly for 12 weeks. The CG had treatment as usual. The spatiotemporal variables of gait were assessed at baseline and post-intervention while walking on two surfaces (even, uneven) under three conditions: regular walking; dual-task: verbal-fluency (DTVERB), and serial-subtraction (DTSUBT). The data were analysed by means of a linear mixed model.
RESULTS
At baseline, there was no significant group difference for any spatiotemporal gait variable. The DG improved significantly compared to the CG with and without a dual task when walking on even surface. During regular walking, DG improved in gait velocity (p = 0.017), cadence (p = 0.039), step length (p = 0.040) and stride length (p = 0.041). During DTVERB significant improvements were noted in gait velocity (p = 0.035), cadence (p = 0.034) and step length (p = 0.039). The DG also exhibited significant improvement compared to the CG during DTSUBT in the measures of gait velocity (p = 0.012), cadence (p = 0.021), step length (p = 0.018), and stride length (p = 0.151). On the uneven surface, improvements were noted when walking while performing serial subtractions only. During regular walking, improvements were noted for the CG but not for the DG. CG has spent less time in double support following the intervention than DG. While DTVERB condition had no significant group differences for any gait parameter (p's >0.05), in the DTSUBT condition, the DG improved significantly compared to the controls on gait velocity (p = 0.048), cadence (p = 0.026), and step length (p = 0.051).
CONCLUSIONS
DfPD®-based classes produced clinically significant improvement in spatiotemporal gait parameters under dual-task conditions and on uneven surfaces. This could arise from improved movement confidence and coordination; emotional expression; cognitive skills (planning, multitasking), and; utilisation of external movement cues. A large-scale RCT of this program is warranted.
TRIAL REGISTRATION
A protocol for this study has been registered retrospectively at the Australian New Zealand Clinical Trials Registry. Identifier: ACTRN12618001834246.
Identifiants
pubmed: 36693038
doi: 10.1371/journal.pone.0280635
pii: PONE-D-22-05307
pmc: PMC9873168
doi:
Banques de données
ANZCTR
['ACTRN12618001834246']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0280635Informations de copyright
Copyright: © 2023 Haputhanthirige et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
I have read the journal’s policy and the authors of this manuscript have the following competing interests. ERJ is the Director of Dance for Parkinson’s Australia and a lead teacher in Dance for Parkinson’s attached to Queensland Ballet. The other authors have no conflicts of interest to declare.
Références
NeuroRehabilitation. 2019;45(2):273-283
pubmed: 31561398
Neurology. 2010 Jul 13;75(2):116-24
pubmed: 20574039
Parkinsons Dis. 2012;2012:918719
pubmed: 22135764
Brain. 2000 Oct;123 ( Pt 10):2077-90
pubmed: 11004125
Phys Ther. 1996 Jul;76(7):763-77; discussion 778-80
pubmed: 8677280
Am J Orthopsychiatry. 1947 Jul;17(3):488-99
pubmed: 20252604
Brain. 1996 Apr;119 ( Pt 2):551-68
pubmed: 8800948
J Orthop Res. 1990 May;8(3):383-92
pubmed: 2324857
J Am Geriatr Soc. 2006 Aug;54(8):1241-4
pubmed: 16913992
Brain. 1983 Jun;106 (Pt 2):257-70
pubmed: 6850270
J Neurol Phys Ther. 2016 Oct;40(4):257-68
pubmed: 27576092
Mov Disord. 2002 Nov;17(6):1148-60
pubmed: 12465051
Mov Disord. 2008 Feb 15;23(3):329-42; quiz 472
pubmed: 18058946
Parkinsonism Relat Disord. 2011 Sep;17(8):610-6
pubmed: 21676644
Gait Posture. 2003 Aug;18(1):35-46
pubmed: 12855299
J Telemed Telecare. 2017 Sep;23(8):740-746
pubmed: 27624469
J Mot Behav. 2013;45(6):519-29
pubmed: 24116748
J Rehabil Med. 2009 May;41(6):475-81
pubmed: 19479161
Disabil Rehabil. 2010;32(8):679-84
pubmed: 20205582
J Appl Gerontol. 2017 Dec;36(12):1519-1533
pubmed: 26912733
J Neurol. 2007 Feb;254(2):202-9
pubmed: 17334954
Front Neurol. 2016 Feb 17;7:15
pubmed: 26925029
Complement Ther Med. 2010 Oct;18(5):184-90
pubmed: 21056841
Neuroimage. 2014 Jan 15;85 Pt 3:1014-26
pubmed: 23727530
Front Aging Neurosci. 2015 Dec 21;7:239
pubmed: 26733865
Am J Epidemiol. 2003 Jun 1;157(11):1015-22
pubmed: 12777365
Mov Disord. 2010 Oct 30;25(14):2369-78
pubmed: 20737542
Parkinsonism Relat Disord. 2012 Jun;18(5):553-6
pubmed: 22405839
Front Neurol. 2015 Nov 11;6:234
pubmed: 26617566
Neurorehabil Neural Repair. 2012 Feb;26(2):132-43
pubmed: 21959675
Phys Ther. 2002 Sep;82(9):888-97
pubmed: 12201803
Ann N Y Acad Sci. 1995 Dec 15;769:161-71
pubmed: 8595023
Mov Disord. 2007 Jan;22(1):41-7
pubmed: 17115387
Eur J Phys Rehabil Med. 2009 Jun;45(2):231-8
pubmed: 19532110
NeuroRehabilitation. 2017;40(1):141-144
pubmed: 27814308
J Neurol Phys Ther. 2014 Oct;38(4):233-8
pubmed: 25198866
Complement Ther Med. 2016 Aug;27:12-7
pubmed: 27515870
J Altern Complement Med. 2014 Oct;20(10):757-63
pubmed: 25192393
Parkinsons Dis. 2012;2012:856237
pubmed: 22191078
J Parkinsons Dis. 2019;9(2):335-349
pubmed: 30958312
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
Arch Phys Med Rehabil. 2015 Jan;96(1):141-53
pubmed: 25223491
J Neural Transm (Vienna). 2015 Sep;122(9):1263-70
pubmed: 25836752
Front Aging Neurosci. 2011 Oct 10;3:14
pubmed: 22013420
J Neural Transm (Vienna). 2006 Feb;113(2):175-85
pubmed: 15959849
Arch Phys Med Rehabil. 2008 Oct;89(10):1970-6
pubmed: 18760402
J Neuroeng Rehabil. 2005 Aug 11;2:26
pubmed: 16095533
Complement Ther Med. 2015 Apr;23(2):210-9
pubmed: 25847558
Neurorehabil Neural Repair. 2010 May;24(4):384-92
pubmed: 20008820
Complement Ther Med. 2015 Apr;23(2):175-84
pubmed: 25847555
J Neurol Neurosurg Psychiatry. 1994 Dec;57(12):1532-4
pubmed: 7798986
Aging Clin Exp Res. 2014 Apr;26(2):201-11
pubmed: 24136448
Contemp Clin Trials. 2016 Nov;51:50-55
pubmed: 27765693
Brain. 1994 Oct;117 ( Pt 5):1169-81
pubmed: 7953597
Phys Ther. 2002 Jul;82(7):670-81
pubmed: 12088464
Aust J Physiother. 2005;51(3):175-80
pubmed: 16137243
Complement Ther Med. 2009 Aug;17(4):203-7
pubmed: 19632547
J Neurol Phys Ther. 2007 Dec;31(4):173-9
pubmed: 18172414
Mov Disord. 2004 Sep;19(9):1020-8
pubmed: 15372591
Am J Med Genet. 1999 Oct 15;88(5):539-43
pubmed: 10490713
Eur J Neurol. 2009 Jan;16(1):142-7
pubmed: 19049504
Mov Disord. 1998 May;13(3):428-37
pubmed: 9613733
Arch Phys Med Rehabil. 2007 Dec;88(12):1593-600
pubmed: 18047873
Eur J Phys Rehabil Med. 2020 Oct;56(5):563-574
pubmed: 32383572